Home » Venture Capital » All Companies

All Companies

Company Description Status Initial Datesort icon
<a href="/venture-capital/all-companies/visen-medical-inc">VisEn Medical, Inc.</a> Pioneering a new era of in vivo imaging. Acquired 2005 View Profile
<a href="/venture-capital/all-companies/resolvyx-pharmaceuticals-inc">Resolvyx Pharmaceuticals, Inc.</a> Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Private 2005 View Profile
<a href="/venture-capital/all-companies/interactive-supercomputing-corporation">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2005 View Profile
<a href="/venture-capital/all-companies/intio">INTIO</a> Developing a software platform to support the emerging interventional oncology market. Private 2005 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Private 2006 View Profile
<a href="/venture-capital/all-companies/t2-biosystems-inc">T2 Biosystems, Inc.</a> Developing next-generation medical diagnostic products. Private 2006 View Profile
<a href="/venture-capital/all-companies/alvine-pharmaceuticals-inc">Alvine Pharmaceuticals, Inc.</a> Developing biologics to target autoimmune/inflammatory diseases. Private 2006 View Profile
<a href="/venture-capital/all-companies/mascoma-corporation">Mascoma Corporation</a> Developing environmentally sustainable, low cost, low carbon biofuels from cellulosic biomass. Private 2006 View Profile
<a href="/venture-capital/all-companies/tetraphase-pharmaceuticals-inc">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. Public 2006 View Profile
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Private 2007 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Pioneering the production of Liquid Fuel from the Sun™. Private 2007 View Profile
<a href="/venture-capital/all-companies/seventh-sense-biosystems-inc">Seventh Sense Biosystems, Inc.</a> Optimizing the interface of diagnostic medicine and the healthcare consumer by simplifying blood sampling and testing. Private 2007 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing a new class of highly selective targeted and programmable therapeutics called Accurins™. Private 2007 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Pioneering a family of high performance, environmentally responsible polymers and chemical intermediates. Private 2007 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing a novel platform for single molecule analysis of proteins. Private 2007 View Profile
<a href="/venture-capital/all-companies/hypnion-inc">Hypnion, Inc.</a> Platform technology enabling novel therapies for treatment of sleep disorders Acquired 2007 View Profile
<a href="/venture-capital/all-companies/selecta-biosciences-inc">Selecta Biosciences, Inc.</a> Developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Private 2008 View Profile
<a href="/venture-capital/all-companies/bizo">Bizo</a> Private 2008 View Profile
<a href="/venture-capital/all-companies/accuri-cytometers-inc">Accuri Cytometers, Inc.</a> Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. Acquired 2008 View Profile
<a href="/venture-capital/all-companies/taris-biomedical-inc">TARIS Biomedical, Inc.</a> Developing local minimally-invasive drug-device convergence products. Private 2008 View Profile